CRISPR Therapeutics AG
CRSP
Market Cap$4.67B
Close$
$-32.85
159.6% downside
Current Fair Value
159.6% downsideOvervalued by 159.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.67 Billion |
|---|---|
| Enterprise Value | $2.98 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.94 |
| Beta | 0.0 |
| Outstanding Shares | 84,883,091 |
| Avg 30 Day Volume | 1,304,120 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -30.43 |
|---|---|
| PEG | 16.83 |
| Price to Sales | 13.77 |
| Price to Book Ratio | 2.5 |
| Enterprise Value to Revenue | 8.03 |
| Enterprise Value to EBIT | -13.39 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni